1. Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010;Kim;BMC Infect Dis,2012
2. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990–2000;Chiavetta;CMAJ,2003
3. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil;Maresch;Transfusion,2008
4. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007;Kafi-abad;Transfusion,2009
5. Trends in seroprevalence of hepatitis B, hepatitis C, HIV, and syphilis infections in Iranian blood donors from 2003 to 2005;Khedmat;Hepat Mon,2009